ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.900
+0.315 (6.87%)
Apr 29, 2026, 9:33 AM EDT - Market open
ENDRA Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.76 | 3.23 | 2.83 | 4.89 | 9.46 | Upgrade
|
| Cash & Short-Term Investments | 0.76 | 3.23 | 2.83 | 4.89 | 9.46 | Upgrade
|
| Cash Growth | -76.39% | 13.96% | -42.04% | -48.33% | 30.91% | Upgrade
|
| Inventory | - | - | - | - | 1.28 | Upgrade
|
| Prepaid Expenses | 0.21 | 0.2 | 0.2 | 0.49 | 1.35 | Upgrade
|
| Total Current Assets | 0.97 | 3.43 | 3.03 | 5.38 | 12.09 | Upgrade
|
| Property, Plant & Equipment | 0.5 | 0.65 | 0.47 | 0.74 | 0.77 | Upgrade
|
| Other Long-Term Assets | 2.38 | 0.37 | 3.26 | 3.15 | 0.01 | Upgrade
|
| Total Assets | 3.85 | 4.45 | 6.75 | 9.27 | 12.87 | Upgrade
|
| Accounts Payable | 0.38 | 0.27 | 0.36 | 0.61 | 0.79 | Upgrade
|
| Accrued Expenses | 0.24 | 0.24 | 0.19 | 0.75 | 0.5 | Upgrade
|
| Short-Term Debt | - | - | 0.15 | 0.16 | 0.12 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 0.03 | 0.03 | - | Upgrade
|
| Current Portion of Leases | 0.13 | 0.1 | 0.17 | 0.15 | 0.13 | Upgrade
|
| Total Current Liabilities | 0.75 | 0.61 | 0.9 | 1.7 | 1.54 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.03 | Upgrade
|
| Long-Term Leases | 0.36 | 0.49 | 0.19 | 0.37 | 0.52 | Upgrade
|
| Other Long-Term Liabilities | 0.48 | 0.8 | - | - | - | Upgrade
|
| Total Liabilities | 1.59 | 1.89 | 1.1 | 2.07 | 2.09 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 112.73 | 106 | 97.58 | 89.07 | 79.46 | Upgrade
|
| Retained Earnings | -110.47 | -103.44 | -91.93 | -81.87 | -68.69 | Upgrade
|
| Comprehensive Income & Other | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Common Equity | 2.26 | 2.56 | 5.66 | 7.2 | 10.78 | Upgrade
|
| Shareholders' Equity | 2.26 | 2.56 | 5.66 | 7.2 | 10.78 | Upgrade
|
| Total Liabilities & Equity | 3.85 | 4.45 | 6.75 | 9.27 | 12.87 | Upgrade
|
| Total Debt | 0.49 | 0.58 | 0.54 | 0.71 | 0.8 | Upgrade
|
| Net Cash (Debt) | 0.27 | 2.65 | 2.29 | 4.18 | 8.67 | Upgrade
|
| Net Cash Growth | -89.79% | 15.47% | -45.25% | -51.72% | 34.18% | Upgrade
|
| Net Cash Per Share | 0.34 | 13.09 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 1.24 | 0.56 | - | - | - | Upgrade
|
| Total Common Shares Outstanding | 1.18 | 0.54 | - | - | - | Upgrade
|
| Working Capital | 0.22 | 2.83 | 2.13 | 3.68 | 10.55 | Upgrade
|
| Book Value Per Share | 1.92 | 4.77 | - | - | - | Upgrade
|
| Tangible Book Value | 2.26 | 2.56 | 5.66 | 7.2 | 10.78 | Upgrade
|
| Tangible Book Value Per Share | 1.92 | 4.77 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.